DE69624485D1 - Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen - Google Patents

Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen

Info

Publication number
DE69624485D1
DE69624485D1 DE69624485T DE69624485T DE69624485D1 DE 69624485 D1 DE69624485 D1 DE 69624485D1 DE 69624485 T DE69624485 T DE 69624485T DE 69624485 T DE69624485 T DE 69624485T DE 69624485 D1 DE69624485 D1 DE 69624485D1
Authority
DE
Germany
Prior art keywords
photosensitizers
monobenzoporhyrine
liposomes containing
producing liposomes
containing hydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69624485T
Other languages
English (en)
Other versions
DE69624485T2 (de
Inventor
Liu Ron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novelion Therapeutics Inc
Original Assignee
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QLT Inc, Quadra Logic Technologies Inc filed Critical QLT Inc
Publication of DE69624485D1 publication Critical patent/DE69624485D1/de
Application granted granted Critical
Publication of DE69624485T2 publication Critical patent/DE69624485T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69624485T 1995-08-02 1996-07-29 Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen Expired - Lifetime DE69624485T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/510,573 US5707608A (en) 1995-08-02 1995-08-02 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
PCT/CA1996/000512 WO1997004746A1 (en) 1995-08-02 1996-07-29 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers

Publications (2)

Publication Number Publication Date
DE69624485D1 true DE69624485D1 (de) 2002-11-28
DE69624485T2 DE69624485T2 (de) 2003-06-26

Family

ID=24031289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69624485T Expired - Lifetime DE69624485T2 (de) 1995-08-02 1996-07-29 Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen

Country Status (12)

Country Link
US (1) US5707608A (de)
EP (1) EP0843547B1 (de)
JP (1) JP3782112B2 (de)
AT (1) ATE226430T1 (de)
AU (1) AU717181B2 (de)
CA (1) CA2227761C (de)
DE (1) DE69624485T2 (de)
DK (1) DK0843547T3 (de)
ES (1) ES2186792T3 (de)
PT (1) PT843547E (de)
TW (1) TW585785B (de)
WO (1) WO1997004746A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69215722T3 (de) * 1991-03-22 2001-03-08 Katsuro Tachibana Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6143287A (en) * 1996-02-27 2000-11-07 New York Blood Center, Inc. Method and composition for hair removal
CA2202103C (en) * 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6582392B1 (en) * 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
WO1999013916A2 (en) * 1997-09-18 1999-03-25 Nycomed Imaging As Methods and compositions for medical imaging
US6183727B1 (en) 1998-05-19 2001-02-06 Arizona Board Of Regents Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
US6608050B2 (en) * 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
CA2714081C (en) 2000-02-10 2013-08-06 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
AR032151A1 (es) 2000-03-24 2003-10-29 Novartis Ag Uso de un farmaco anti-angiogenico en conjunto con un agente fotosensible para la preparacion de un medicamento para el tratamiento fotodinamico mejorado de la neovasculatura indeseada
US8106038B2 (en) 2001-02-15 2012-01-31 Qlt Inc. Method for reducing or preventing PDT related inflammation
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
AU2007202603B2 (en) * 2001-04-11 2010-06-10 Valeant Pharmaceuticals International, Inc. Drug delivery system for hydrophobic drugs
DE60225844T2 (de) * 2001-11-02 2009-04-09 The Governors Of The University Of Alberta, Edmonton Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
US7220239B2 (en) 2001-12-03 2007-05-22 Ekos Corporation Catheter with multiple ultrasound radiating members
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US7455858B2 (en) * 2002-05-16 2008-11-25 Qlt Inc. Compositions and methods for delivery of photosensitive drugs
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
JP4741205B2 (ja) * 2003-07-07 2011-08-03 真 湯浅 金属ポルフィリン錯体包埋リポソーム、その製造方法およびこれを利用する医薬
US7682603B2 (en) * 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US7341569B2 (en) * 2004-01-30 2008-03-11 Ekos Corporation Treatment of vascular occlusions using ultrasonic energy and microbubbles
US7419666B1 (en) 2004-02-23 2008-09-02 Massachusetts Eye And Ear Infirmary Treatment of ocular disorders
JP2008536562A (ja) * 2005-04-12 2008-09-11 イコス コーポレイション 空洞形成推進面が設けられた超音波カテーテル
US20070265560A1 (en) * 2006-04-24 2007-11-15 Ekos Corporation Ultrasound Therapy System
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
WO2008088037A1 (ja) * 2007-01-18 2008-07-24 National University Corporation Chiba University 微粒子製剤
WO2009002881A1 (en) 2007-06-22 2008-12-31 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
WO2009079415A1 (en) * 2007-12-14 2009-06-25 Ekos Corporation Ultrasound pulse shaping
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
CN107613962B (zh) * 2015-04-02 2021-02-09 纽约州立大学研究基金会 血清稳定组合物和用于光触发的材料释放的方法
CN107708581B (zh) 2015-06-10 2021-11-19 Ekos公司 超声波导管
EP3463574B1 (de) 2016-05-26 2021-11-03 University of Pittsburgh- Of the Commonwealth System of Higher Education Zusammensetzungen und verfahren zur behandlung von lungengefässerkrankung
KR102035384B1 (ko) * 2017-06-26 2019-10-22 서강대학교산학협력단 광감작제를 포함한 마이크로버블-나노입자 복합체 및 이를 포함하는 항암 치료제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4517762A (en) * 1983-07-08 1985-05-21 Venetz Louis M Animal trap holder
US4485806A (en) * 1983-10-24 1984-12-04 Calspan Corporation Method and apparatus for evacuating contaminated casualties
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4933121A (en) * 1986-12-10 1990-06-12 Ciba Corning Diagnostics Corp. Process for forming liposomes
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5422362A (en) * 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis

Also Published As

Publication number Publication date
AU6608396A (en) 1997-02-26
ATE226430T1 (de) 2002-11-15
EP0843547A1 (de) 1998-05-27
PT843547E (pt) 2003-03-31
ES2186792T3 (es) 2003-05-16
DE69624485T2 (de) 2003-06-26
TW585785B (en) 2004-05-01
CA2227761C (en) 2004-01-06
DK0843547T3 (da) 2003-02-24
AU717181B2 (en) 2000-03-16
WO1997004746A1 (en) 1997-02-13
US5707608A (en) 1998-01-13
CA2227761A1 (en) 1997-02-13
EP0843547B1 (de) 2002-10-23
JP3782112B2 (ja) 2006-06-07

Similar Documents

Publication Publication Date Title
DE69624485T2 (de) Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen
ATE397488T1 (de) Vorrichtung zur herstellung von liposomen
ATE82495T1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
DK0524968T3 (da) Heterovesikulære lipidvesikler
ES2153053T3 (es) Liposomas de eter-lipido y su uso terapeutico.
ATE192924T1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
ATE203898T1 (de) Verfahren zur herstellung einer liposomen- zubereitung
ATE264859T1 (de) Neue adenosin-monophosphat-deaminase-inhibitoren
GR3018810T3 (en) 5,6-dihydroxyindoline as additives for hair-dyeing preparations.
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
JPS6450812A (en) Hair dye composition and use
ATE233484T1 (de) Desinfizierende zusammensetzung
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
ATE248156T1 (de) Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen
JPS55160712A (en) Emulsified cosmetic composition
ATE332905T1 (de) Verfahren zur herstellung von acylphosphinoxiden
DE69333060T2 (de) Methoden zur herstellung praktisch reiner eg iii zellulase mittels alkohol
DE69823064D1 (de) Verfahren zur herstellung von schwach gefärbten bis transparenten alkylglykosiden
DE59914774D1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
BR9507135A (pt) Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética
DE69514512T2 (de) Verfahren zur herstellung von benzopyranderivaten
DE50104689D1 (de) Verfahren zur herstellung von waschmittelgranulaten
ATE304298T1 (de) Verfahren zur herstellung von fleischprodukten
ES2138292T3 (es) Compuestos alquilsubstituidos c1-c3 alcoxi-ciclohexano o -benceno, utilizacion organoleptica de los mismos y procedimiento para su fabricacion.
ATE212966T1 (de) Verfahren zur herstellung von 3,3- dimethylbutyraldehyd

Legal Events

Date Code Title Description
8364 No opposition during term of opposition